ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Bicycle Therapeutics PLC

Bicycle Therapeutics PLC (BCYC)

23.97
-1.44
(-5.67%)
Closed September 23 4:00PM
23.97
0.00
( 0.00% )
Pre Market: 6:13AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
23.97
Bid
9.59
Ask
24.95
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
23.97
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
68,993,458
Dividend Yield
-
PE Ratio
-9.15
Earnings Per Share (EPS)
-2.62
Revenue
26.98M
Net Profit
-180.66M

About Bicycle Therapeutics PLC

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused... Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Cambridge, Gbr
Founded
-
Bicycle Therapeutics PLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker BCYC. The last closing price for Bicycle Therapeutics was $23.97. Over the last year, Bicycle Therapeutics shares have traded in a share price range of $ 0.00 to $ 0.00.

Bicycle Therapeutics currently has 68,993,458 shares outstanding. The market capitalization of Bicycle Therapeutics is $1.65 billion. Bicycle Therapeutics has a price to earnings ratio (PE ratio) of -9.15.

Bicycle Therapeutics (BCYC) Options Flow Summary

Overall Flow

Bullish

Net Premium

63k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

BCYC Latest News

Bicycle Therapeutics Presents Updated Clinical Results Across Oncology Pipeline at ESMO Congress 2024

Updated monotherapy data for Nectin-4 targeting zelenectide pevedotin in metastatic urothelial cancer (mUC) showed a promising 45% overall response rate (ORR), 11.1 months median duration of...

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Bicycle Therapeutics plc (NASDAQ: BCYC), today announced that on September 3, 2024, the Compensation Committee of the company’s Board of Directors granted to seven new employees inducement awards...

Bicycle Therapeutics to Participate in Upcoming Investor Conferences

Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today...

Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2024 Financial Results

Four abstracts containing data updates across clinical pipeline accepted for poster presentation at ESMO Congress 2024 Focused R&D pipeline on clinical programs and research areas that have...

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Bicycle Therapeutics plc (NASDAQ: BCYC) today announced that on August 1, 2024, the Compensation Committee of the company’s Board of Directors granted to seven new employees inducement awards...

Bicycle Therapeutics Announces Four Abstracts Accepted for Presentation at the ESMO Congress 2024

Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MSSMaison Solutions Inc
$ 1.43
(100.00%)
2.83M
HSCSHeart Test Laboratories Inc
$ 5.08
(72.79%)
2.36M
MLGOMicroAlgo Inc
$ 0.2795
(40.88%)
23.33M
GBNYGenerations Bancorp NY Inc
$ 15.40
(40.00%)
100.57k
BAOSBaosheng Media Group Holdings Ltd
$ 2.84
(30.47%)
9
NOTVInotiv Inc
$ 0.65
(-59.38%)
107
BIVIBioVie Inc
$ 1.32
(-52.86%)
77.31k
GHSIGuardion Health Sciences Inc
$ 5.92
(-43.73%)
1.54k
TOIIWOncology Institute Inc
$ 0.014
(-25.13%)
23k
FRESFresh2 Group Ltd
$ 1.50
(-17.58%)
18.43k
MLGOMicroAlgo Inc
$ 0.2793
(40.78%)
23.33M
NUKKNukkleus Inc
$ 0.2711
(7.79%)
3.09M
MSSMaison Solutions Inc
$ 1.43
(100.00%)
2.83M
XTKGX3 Holdings Company Ltd
$ 0.1761
(-7.95%)
2.64M
DUOFangDD Network Group Ltd
$ 0.4595
(7.24%)
2.39M

Your Recent History

Delayed Upgrade Clock